Zak Lourie S.
SEC CIK 1991207 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GNLX | GENELUX Corp | CFO | 82.5K | — | $4,921 | 4 | 2024-02-19 | 2024-12-18 |
Most active insiders at GNLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zindrick Thomas | Pres, CEO | — | $117.7K |
| 2 | Thomas John | Dir | — | $108.8K |
| 3 | Smither John W | Dir | — | $34.9K |
| 4 | Cappello Joseph | Chief Technical Off | — | $34.0K |
| 5 | Yu Yong | SVP, Clinical Development | — | $32.6K |
| 6 | Smalling Ralph | Head of Regulatory | — | $2,804 |
| 7 | Pulisic Matthew | CFO | — | — |
| 8 | Mirabelli Mary | Dir | — | — |
| 9 | Groen Eric | GC | — | — |
| 10 | Tyree James L | Dir | — | — |
Zak Lourie S. made no open-market trades at GNLX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-20 | 2024-12-18 | GNLX | GENELUX Corp | Zak Lourie S. | CFO | A - Grant | $0.00 | +41.6K | 82.5K | +102% | $0 |
| 2024-12-18 | 2024-12-16 | GNLX | GENELUX Corp | Zak Lourie S. | CFO | S - Sale | $2.34 | -2,103 | 40.8K | -5% | -$4,921 | |
| M | 2024-07-08 | 2024-02-19+ | GNLX | GENELUX Corp | Zak Lourie S. | CFO | A - Grant | $0.00 | +5,072 | 32.5K | +19% | $0 |
| D | 2024-06-07 | 2024-05-29 | GNLX | GENELUX Corp | Zak Lourie S. | CFO | P - Purchase | — | +31.2K | 31.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations